GlassScriptPhysician profile
Austin Thomas Fragomen
NPI 1366453235
$245,638.02
in general payments reported to CMS, 2019-2025
12 companies · $31K in 2025
The $31K reported for 2025 was more than what 93% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46K · 2020: $22K · 2021: $41K · 2022: $60K · 2023: $30K · 2024: $16K · 2025: $31K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $50K · Royalty Or License: $15K · Travel and Lodging: $6,463 · Honoraria: $3,761 · Food and Beverage: $1,385.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $49,992.73 |
| Royalty Or License | $15,355.75 |
| Travel and Lodging | $6,462.71 |
| Honoraria | $3,760.50 |
| Food and Beverage | $1,385.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $146,756.12 | 2019-2024 | Na |
| Globus Medical, INC. | $31,020.50 | 2023-2025 | Precice® Intramedullary Limb Lengthening System, Autobahn, Distal Femur Plate System |
| Nuvasive Specialized Orthopedics, INC. | $28,708.38 | 2019-2023 | Precice Intramedullary Limb Lengthening System |
| Smith+Nephew, INC. | $15,865.17 | 2019-2025 | Pico 7, Renasys Touch |
| Synthes USA Products LLC | $11,945.83 | 2019-2022 | |
| Synthes Gmbh | $10,287.50 | 2022-2023 | |
| Stryker Corporation | $834.81 | 2019-2025 | T2 Alpha, Pangea, Variax |
| Depuy Synthes Sales INC. | $106.61 | 2022 | |
| Bone Support INC. | $35.66 | 2019 | |
| My01 INC. | $34.26 | 2024 | My01 Continuous Compartmental Pressure Monitor |
| Paragon 28, INC. | $24.85 | 2019 | |
| Axogen | $18.33 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Austin Fragomen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.